Lyra Therapeutics, Inc. (32) | Business Operations (2)
- License and Collaboration Agreement dated May 31, 2021, by and between the Registrant and LianBio Inflammatory Limited and LianBio (Filed With SEC on August 9, 2021)
- Form of Indemnification Agreement for directors and officers of the Registrant (Filed With SEC on April 27, 2020)